Product Images Duloxetine Delayed-release

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Duloxetine Delayed-release NDC 51407-817 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51407-817-60LB - DULOXETINE 20MG DR CAPS - REV 07-23.jpg - 51407 817 60LB DULOXETINE 20MG DR CAPS REV 07 23

51407-817-60LB - DULOXETINE 20MG DR CAPS - REV 07-23.jpg - 51407 817 60LB   DULOXETINE 20MG DR CAPS   REV 07 23

51407-818-30LB - DULOXETINE 30MG DR CAPS - REV 07-23.jpg - 51407 818 30LB DULOXETINE 30MG DR CAPS REV 07 23

51407-818-30LB - DULOXETINE 30MG DR CAPS - REV 07-23.jpg - 51407 818 30LB   DULOXETINE 30MG DR CAPS   REV 07 23

This is a description for a medication containing duloxetine hydrochloride. Each capsule contains 33.7 mg of duloxetine hydrochloride, which is equivalent to 30 mg of duloxetine. The recommended dosage can be found in the accompanying Delayed-Release Prescribing Information. The pharmacist should dispense the Medication Guide to each patient, which can be printed from the website provided. The medication should be dispensed in a tightly closed container and stored at a temperature of 25°C (77°F), with excursions permitted between 15° - 30°C (59° - 86°F). It is important to keep this medication out of the reach of children. Marketed by GSMS, Incorporated.*

51407-819-30LB - DULOXETINE 60MG DR CAPS - REV 07-23.jpg - 51407 819 30LB DULOXETINE 60MG DR CAPS REV 07 23

51407-819-30LB - DULOXETINE 60MG DR CAPS - REV 07-23.jpg - 51407 819 30LB   DULOXETINE 60MG DR CAPS   REV 07 23

Each capsule of this medication contains 67.3 mg of duloxetine hydrochloride, which is equivalent to 60 mg of duloxetine according to the USP standards. This information is provided by NDC 51407-819-30. The recommended dosage can be found in the accompanying Delayed-Release Prescribing Information. Pharmacists are advised to dispense the Medication Guide to each patient, which can be printed from the website https://gsms.us/. The medication should be dispensed in a tightly closed container and kept out of the reach of children. The product can be stored at a temperature of 25°C (77°F), with excursions permitted between 15° - 30°C (59° - 86°F). This medication is marketed by GSMS, Incorporated and is only available by prescription.*

Chemical Structure - duloxetine 01

Chemical Structure - duloxetine 01

Figure 1 - duloxetine 02

Figure 1 - duloxetine 02

Figure 2 - duloxetine 03

Figure 2 - duloxetine 03

Not available*

Figure 3 - duloxetine 04

Figure 3 - duloxetine 04

Figure 4 - duloxetine 05

Figure 4 - duloxetine 05

Figure 5 - duloxetine 06

Figure 5 - duloxetine 06

Figure 6 - duloxetine 07

Figure 6 - duloxetine 07

Figure 8 - duloxetine 08

Figure 8 - duloxetine 08

Figure 9 - duloxetine 09

Figure 9 - duloxetine 09

Figure 10 - duloxetine 10

Figure 10 - duloxetine 10

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.